These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7509090)

  • 1. Effect of asialofetuin on prolongation of skin allograft survival by donor bone marrow cells.
    Khouri W; Masli S; De Fazio SR; Gozzo JJ
    Transplantation; 1994 Feb; 57(3):440-6. PubMed ID: 7509090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
    De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
    Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
    Masli S; De Fazio SR; Gozzo JJ
    Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.
    Goldstein DR; Thomas JM; Kirklin JK; George JF
    Transplantation; 2001 Sep; 72(5):954-6. PubMed ID: 11571465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells.
    De Fazio SR; Masli S; Gozzo JJ
    Transplantation; 1996 Jan; 61(1):104-10. PubMed ID: 8560547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of secondary skin allograft rejection by veto-like cells in donor bone marrow.
    Pourshadi M; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Aug; 56(2):385-90. PubMed ID: 8356595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.
    Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
    Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic behavior of skin allografts from neonatal mice.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells.
    Monaco AP; Wood ML; Gottschalk R; Seiler FR
    Transplantation; 1991 Jan; 51(1):213-8. PubMed ID: 1670970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of adult skin allograft survival by cotransplantation of neonatal skin in antilymphocyte serum and donor bone marrow cell-treated mice.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1990 Dec; 50(6):911-4. PubMed ID: 2256160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the liver sequestration of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor.
    Samlowski WE; Spangrude GJ; Daynes RA
    Cell Immunol; 1984 Oct; 88(2):309-22. PubMed ID: 6207941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice.
    Wood ML; Orosz CG; Gottschalk R; Monaco AP
    Transplantation; 1992 Oct; 54(4):665-71. PubMed ID: 1412758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice.
    Dono K; Wood ML; Ozato H; Otsu I; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1995 Apr; 59(7):929-32. PubMed ID: 7709451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.